For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
ReShape Lifesciences Inc (NASDAQ: RSLS) closed the day trading at $1.12 down -8.94% from the previous closing price of $1.23. In other words, the price has decreased by -$8.94 from its previous closing price. On the day, 2.01 million shares were traded.
Ratios:
For a better understanding of RSLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.05.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 31 ’24 when STANKOVICH THOMAS sold 48 shares for $0.25 per share. The transaction valued at 12 led to the insider holds 22,777 shares of the business.
STANKOVICH THOMAS sold 43 shares of RSLS for $7 on Feb 29 ’24. The Chief Financial Officer now owns 22,825 shares after completing the transaction at $0.17 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.10 while its Price-to-Book (P/B) ratio in mrq is 0.53.
Stock Price History:
Over the past 52 weeks, RSLS has reached a high of $29.00, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is -71.58%, while the 200-Day Moving Average is calculated to be -85.60%.
Shares Statistics:
A total of 0.70M shares are outstanding, with a floating share count of 0.69M. Insiders hold about 5.17% of the company’s shares, while institutions hold 4.57% stake in the company.
